Interleukin -1β Promotes Lung Adenocarcinoma Growth and Invasion Through Promoting Glycolysis Via P38 Pathway

Overview

Journal J Inflamm Res

Publisher Dove Medical Press

Date 2021 Dec 9

PMID 34880649

Citations 8

Authors

Qi Tan

Limin Duan

Qi Huang

Wenjuan Chen

Zimo Yang

Jiangbin Chen

Yang Jin

Affiliations

Soon will be listed here.

Abstract

Background: There is a close relationship among inflammation, glycolysis, and tumors. The IL-1 family includes important inflammatory cytokines, among which IL-1β has been widely studied. In this study, we focused on the effect of IL-1β on glycolysis of lung adenocarcinoma (LUAD) cells in vivo and in vitro and explored its possible mechanisms.

Methods: A bioinformatic database and quantitative real-time PCR were used to analyze the expression of glycolysis-related enzyme genes and their correlations with IL1β in human LUAD samples. The human LUAD cell line A549 and Lewis lung carcinoma LLC cell line were stimulated with IL-1β. In vitro treatment effects, including glycolysis level, migration, and invasion were evaluated with a glucose assay kit, lactate assay kit, Western blotting, wound healing, and the transwell method. We established a mouse model of subcutaneous tumors using LLC cells pretreated with IL-1β and analyzed in vivo treatment effects through positron-emission tomography-computed tomography and staining. Virtual screening and molecular dynamic simulation were used to screen potential inhibitors of IL-1β.

Results: Our results showed that IL1β was positively correlated with the expression of glycolysis-related enzyme genes in LUAD. Glycolysis, migration, and invasion significantly increased in A549 and LLC stimulated with IL-1β. In vivo, IL-1β increased growth, mean standard uptake value, and pulmonary tumor metastasis, which were inhibited by the glycolysis inhibitor 2-deoxy-D-glucose and p38-pathway inhibitors. Small molecular compound ZINC14610053 was suggested being a potential inhibitor of IL-1β.

Conclusion: IL-1β promotes glycolysis of LUAD cells through p38 signaling, further enhancing tumor-cell migration and invasion. These results show that IL-1β links inflammation to glycolysis in LUAD, and targeting IL-1β and the glycolysis pathway may be a potential therapeutic strategy for lung cancer.

Citing Articles

Correlation Analysis of Pyroptosis-Related Genes CASP1, NLRP3, AIM2, and NLRP1 With Lung Adenocarcinoma.

Zhu L, Zhang Y, Chen X, Li Y, Pan H, Wang Y Int J Genomics. 2025; 2025:8282590.

PMID: 40026444 PMC: 11871981. DOI: 10.1155/ijog/8282590.

Exploring the relationship between the interleukin family and lung adenocarcinoma through Mendelian randomization and RNA sequencing analysis.

Zhi F, Liu W, Yang H, Luo H, Feng Y, Lei Y Discov Oncol. 2024; 15(1):436.

PMID: 39264458 PMC: 11393260. DOI: 10.1007/s12672-024-01325-1.

Glycolysis and beyond in glucose metabolism: exploring pulmonary fibrosis at the metabolic crossroads.

Wang Y, Wang X, Du C, Wang Z, Wang J, Zhou N Front Endocrinol (Lausanne). 2024; 15:1379521.

PMID: 38854692 PMC: 11157045. DOI: 10.3389/fendo.2024.1379521.

Ubiquitin-specific protease 54 regulates GLUT1-mediated aerobic glycolysis to inhibit lung adenocarcinoma progression by modifying p53 degradation.

Chen L, Zhang L, He H, Shao F, Yu Z, Gao Y Oncogene. 2024; 43(26):2025-2037.

PMID: 38744954 DOI: 10.1038/s41388-024-03047-8.

HCMV-IE2 promotes atherosclerosis by inhibiting vascular smooth muscle cells' pyroptosis.

Ma G, Yu Z, Nan F, Zhang X, Jiang S, Wang Y Front Microbiol. 2023; 14:1177391.

PMID: 37234524 PMC: 10206012. DOI: 10.3389/fmicb.2023.1177391.

References

Siegel R, Miller K, Jemal A . Cancer statistics, 2020. CA Cancer J Clin. 2020; 70(1):7-30. DOI: 10.3322/caac.21590. View

Tang Z, Kang B, Li C, Chen T, Zhang Z . GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019; 47(W1):W556-W560. PMC: 6602440. DOI: 10.1093/nar/gkz430. View

Revu S, Wu J, Henkel M, Rittenhouse N, Menk A, Delgoffe G . IL-23 and IL-1β Drive Human Th17 Cell Differentiation and Metabolic Reprogramming in Absence of CD28 Costimulation. Cell Rep. 2018; 22(10):2642-2653. PMC: 5884137. DOI: 10.1016/j.celrep.2018.02.044. View

Xiao M, Xie J, Wu Y, Wang G, Qi X, Liu Z . The eEF2 kinase-induced STAT3 inactivation inhibits lung cancer cell proliferation by phosphorylation of PKM2. Cell Commun Signal. 2020; 18(1):25. PMC: 7020344. DOI: 10.1186/s12964-020-0528-y. View

Huang Q, Duan L, Qian X, Fan J, Lv Z, Zhang X . IL-17 Promotes Angiogenic Factors IL-6, IL-8, and Vegf Production via Stat1 in Lung Adenocarcinoma. Sci Rep. 2016; 6:36551. PMC: 5098156. DOI: 10.1038/srep36551. View

Tan Q, Huang Q, Ma Y, Mao K, Yang G, Luo P . Potential roles of IL-1 subfamily members in glycolysis in disease. Cytokine Growth Factor Rev. 2018; 44:18-27. DOI: 10.1016/j.cytogfr.2018.11.001. View

Shikhman A, Brinson D, Valbracht J, Lotz M . Cytokine regulation of facilitated glucose transport in human articular chondrocytes. J Immunol. 2001; 167(12):7001-8. DOI: 10.4049/jimmunol.167.12.7001. View

Ding J, Karp J, Emadi A . Elevated lactate dehydrogenase (LDH) can be a marker of immune suppression in cancer: Interplay between hematologic and solid neoplastic clones and their microenvironments. Cancer Biomark. 2017; 19(4):353-363. DOI: 10.3233/CBM-160336. View

Lu J, Xu Z, Duan H, Ji H, Zhen Z, Li B . Tumor-associated macrophage interleukin-β promotes glycerol-3-phosphate dehydrogenase activation, glycolysis and tumorigenesis in glioma cells. Cancer Sci. 2020; 111(6):1979-1990. PMC: 7293068. DOI: 10.1111/cas.14408. View

10.

Oskam R, Rijksen G, Staal G, Vora S . Isozymic composition and regulatory properties of phosphofructokinase from well-differentiated and anaplastic medullary thyroid carcinomas of the rat. Cancer Res. 1985; 45(1):135-42. View

11.

Weber A, Wasiliew P, Kracht M . Interleukin-1 (IL-1) pathway. Sci Signal. 2010; 3(105):cm1. DOI: 10.1126/scisignal.3105cm1. View

12.

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

13.

Bent R, Moll L, Grabbe S, Bros M . Interleukin-1 Beta-A Friend or Foe in Malignancies?. Int J Mol Sci. 2018; 19(8). PMC: 6121377. DOI: 10.3390/ijms19082155. View

14.

Tulotta C, Ottewell P . The role of IL-1B in breast cancer bone metastasis. Endocr Relat Cancer. 2018; 25(7):R421-R434. PMC: 5987176. DOI: 10.1530/ERC-17-0309. View

15.

Yao A, Xiang Y, Si Y, Fan L, Li J, Li H . PKM2 promotes glucose metabolism through a let-7a-5p/Stat3/hnRNP-A1 regulatory feedback loop in breast cancer cells. J Cell Biochem. 2018; 120(4):6542-6554. DOI: 10.1002/jcb.27947. View

16.

Osthus R, Shim H, Kim S, Li Q, Reddy R, Mukherjee M . Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. J Biol Chem. 2000; 275(29):21797-800. DOI: 10.1074/jbc.C000023200. View

17.

Li T, Fan J, Wang B, Traugh N, Chen Q, Liu J . TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017; 77(21):e108-e110. PMC: 6042652. DOI: 10.1158/0008-5472.CAN-17-0307. View

18.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

19.

Fu J, McDonald V, Baines K, Gibson P . Airway IL-1β and Systemic Inflammation as Predictors of Future Exacerbation Risk in Asthma and COPD. Chest. 2015; 148(3):618-629. DOI: 10.1378/chest.14-2337. View

20.

Apte R, Dotan S, Elkabets M, White M, Reich E, Carmi Y . The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev. 2006; 25(3):387-408. DOI: 10.1007/s10555-006-9004-4. View